Copyright ©2025 8th WBC | All Rights Reserved | Powered by Lenagroup
- Terms and conditions
- Privacy Policy
- Cookies Policy
Dear Colleagues & Friends,
We are delighted to invite you to join us at the World Bronchiectasis Conference, Brisbane, Australia 14 to 17 July 2025.
We stand at the cusp of a new era for the international bronchiectasis community where bronchiectasis has emerged from its history as a neglected, orphan condition to emerge as a new, visionary speciality area where enthusiastic and dynamic researchers are shaping a rapidly progressing future.
Dive into key topics at the World Bronchiectasis Conference, where we explore the complexities of bronchiectasis from its causes and underlying mechanisms to innovative treatments. Engage with cutting-edge research on genomics, diverse infections, the impact of environmental factors, and the latest therapeutic strategies.
Join global experts in addressing critical aspects of respiratory health in Brisbane.
(including inflammation, genomics, etc. and differences among diverse populations.)
Alpha-1 Antitrypsin Deficiency
(including not pulmonary ones)
(including ABPA, Pseudomonas, Haemophilus, etc.)
(including gut / lung microbiota interactions)
Nontuberculous mycobacteria
Primary Ciliary Dyskinesia
Registrations and call for abstracts are open
Call for abstracts closing
Early registrations deadline
Meet the Organising Committee of the World Bronchiectasis Conference, composed of leading experts dedicated to advancing the field of respiratory health.
Chaired by top academics and clinicians, including Lucy Burr, Lucy Morgan, and Rachel Thomson, our committee brings a wealth of experience in respiratory medicine, clinical research, and patient care.
Their collective expertise spans across groundbreaking areas like bronchiectasis, NTM infections, and respiratory infectious diseases, ensuring a comprehensive and forward-thinking conference agenda.
Organising and Sponsors Secretariat:
PUBLI CREATIONS S.A.M.
+377 97 97 35 55
wbc@lena.events
Receive updates and news about the congress directly into your inbox
Copyright ©2025 8th WBC | All Rights Reserved | Powered by Lenagroup
Dear Colleagues & Friends,
We are delighted to invite you to join us at the World Bronchiectasis Conference, Brisbane, Australia 14 to 17 July 2025.
We stand at the cusp of a new era for the international bronchiectasis community where bronchiectasis has emerged from its history as a neglected, orphan condition to emerge as a new, visionary speciality area where enthusiastic and dynamic researchers are shaping a rapidly progressing future.
The patient’s voice has been finally heard and researchers, clinicians and industry are now actively collaborating to provide solutions to improve the patient journey through timely precise diagnosis, multidisciplinary management and dedicated treatments.
The 2025 World Bronchiectasis Conference will focus on the diverse nature of bronchiectasis aetiology, management and care and work together to develop inclusive solutions that fulfil the needs of all patients.
The 2025 Australian conference will bring together a diverse field of experts including all members of the multidisciplinary team, fostering an open dialogue between medical specialists, paediatricians, GPs, physiotherapists, nurses, student, researchers and biotechnological companies as well as scientific and patient associations to further our understanding of, not only the physiopathological mechanisms behind the disease, but also the future of therapeutics and everything in-between.
Another commitment the conference has taken is to nurture the next generation of leaders in the field through initiatives such as the Rising Stars program. By providing a platform for junior doctors, researchers, and clinicians to showcase their work and engage with seasoned experts, the conference serves as a catalyst for professional development and mentorship.
Bronchiectasis stands on the threshold of a new age of exciting developments.
Within this exciting context, we invite you to participate and contribute to the next World Bronchiectasis Conference and work together with us to create a better future for our patients with bronchiectasis.
Yours Sincerely,
Lucy Burr, Lucy Morgan, Rachel Thomson
Associate Professor at the School of Medicine, University of Queensland (UQ).
Deputy Head Medical School (Wellbeing and Success), UQ.
Respiratory physician, training supervisor and clinical trials researcher at Mater Health and Mater Research – UQ.
Director of Respiratory, Sleep and Cystic Fibrosis medicine at the Mater Hospital, Brisbane.
Past – chair (2023) of the Acute and Critical Care panel for the National COVID-19 clinical evidence taskforce and member of the guideline leadership group.
Recent (2019- 2021) convenor of the respiratory infectious disease special interest group of the Thoracic Society of Australia and New Zealand (TSANZ).
Queensland TSANZ branch president and past president (2017-2020).
Recent board director of the TSANZ national body and current Chair of the Australasian Bronchiectasis Consortium.
Serving as TSANZ annual scientifi c meeting and World Bronchiectasi Conference Organising Committee.
Professor at the University of Sydney, Australia.
Adult respiratory and sleep physician. Her clinical practice covers a wide range of lung problems including airwaysdiseases (asthma and COPD, bronchiectasis), pulmonary fi brosis, lung infections and lung cancer. Committed to amultidisciplinary approach to respiratory health care.
She has academic appointments at Macquarie University and Sydney University with a strong interest in teachingand training junior doctors and lung researchers throughout the Macquarie University Hospital, Nepean Hospital andConcord Hospital Clinical Schools.
Past chair of the Australasian Bronchiectasis Consortium and clinical lead for the Australian Bronchiectasis Registryproject.
Past – president of the New South Wales chapter of the Thoracic Society of Australiana and New Zealand.
Director of Lung Foundation Australia, a member of the Australian Lung Cancer Trials Group.
Director of Research for the Nepean Lung Cancer Group.
Respiratory physician, specialised in bronchiectasis and NTM infections.
Professor at the University of Queensland, head of the Greenslopes Clinical Unit, Faculty of Medicine, and leader ofthe Mycobacterial Diseases & Bronchiectasis Research group.
Australia’s leading clinician-scientist in the fi eld of NTM lung infections.
Through international connections, she was instrumental in establishing the Australian Bronchiectasis Registry.
Initiator of the Australian NTM Research Consortium.
In addition to her current roles, she has held several leadership roles within the American Thoracic Society, including board member and Chair of the Pulmonary Infections and TB Assembly (2020-22).